Layout
Antibiotics & Anti-Infectives :

   In an era of rising rates of bacterial infections, we offer comprehensive range of highly effective antibiotic and anti-infective injectables. Available at competitive prices, these are specially designed to fulfill the standards of international quality and safety and hence, are in huge demand among healthcare professionals. We offer the following antibiotic and anti-infective injectables:
  • Acyclovir Injection
  • Cefoperazone Injection
  • Amphotericin-B Injection
  • Ceftazidime Injection
  • Cefotaxime Injection
  • Ceftriaxone Injection
  • Cefuroxime Injection
  • Meropenem Injection
  • Tobramycin Injection
  • Clindamycin Injection
  • Gentamicin Injection
  • Amoxicillin Injection
  • Aztreonam Injection
  • Amrinone Injection
  • Aprotinin Injection
  • Gemcitabine Injection
  • Gemcitabine Injection
  • Atracurium Injection
  • Azithromycin Injection
  • Cefepime Injection
  • Ceftizomine Injection
  • Ertapenem Injection
  • Mitomycin Injection
  • Teicoplanin Injection
  • Vancomycin Injection

Marketing is redefined with
informative and innovative
professionals with people
focus
Bulk Drug Manufacturing
industry made itsstunning
heights with Lividus
pharma..
+91 - 4761234567
News and Events



  • ClinTec International, Global CRO, ranked in Deloitte UK Technology Fast 50 & Fast 500 EMEA League of fast growing technology companies.

  • Cell Biologist Joins Adult Stem Cell Research Company, TCA Cellular Therapy

  • TriPoint Global Research Announces Investment Opinion on China Pharmaceuticals, Inc.

  • Pfizer CEO change could signal strategic switch

  • Credit Suisse shuffles pharma-sector ratings

  • Healthcare Reform: Overcoming Hurdles and Building Up Successes

  • AUXILIO signs long-term Managed Print Services contracts with St. Joseph Health System hospitals in Sonoma and Napa counties, CA

  • New Survey of Breast Cancer Patients Shows That Women Taking Tamoxifen Want a CYP2D6 Genetic Test

  • Apricus Biosciences Launches Educational Video Series Focused On Its Newly Approved Erectile Dysfunction Drug, Vitaros®

  • Hemolysis Is Associated with Increased Mortality and Thrombosis in Patients with PNH

  • EHSI: Celulas Genetica Eyes China for Testing New Stem Cell Procedure

  • Operational Excellence for Pharmaceuticals, Biotech and Medical Devices

  • BIT's 2nd Annual International Congress of Cardiology

  • Winning in The New Competitive Pharma Market

  • Health Technology Assessment World Europe 2010

  • Innovation in Drug Discovery: Science & Technology

  • Innovation in Clinical Design: Analysis and Reporting

  • ClinTec International, Global CRO, ranked in Deloitte UK Technology Fast 50 & Fast 500 EMEA League of fast growing technology companies.

  • Cell Biologist Joins Adult Stem Cell Research Company, TCA Cellular Therapy

  • TriPoint Global Research Announces Investment Opinion on China Pharmaceuticals, Inc.

  • Pfizer CEO change could signal strategic switch

  • Credit Suisse shuffles pharma-sector ratings

  • Healthcare Reform: Overcoming Hurdles and Building Up Successes

  • AUXILIO signs long-term Managed Print Services contracts with St. Joseph Health System hospitals in Sonoma and Napa counties, CA

  • New Survey of Breast Cancer Patients Shows That Women Taking Tamoxifen Want a CYP2D6 Genetic Test

  • Apricus Biosciences Launches Educational Video Series Focused On Its Newly Approved Erectile Dysfunction Drug, Vitaros®

  • Hemolysis Is Associated with Increased Mortality and Thrombosis in Patients with PNH

  • EHSI: Celulas Genetica Eyes China for Testing New Stem Cell Procedure

  • Operational Excellence for Pharmaceuticals, Biotech and Medical Devices

  • BIT's 2nd Annual International Congress of Cardiology

  • Winning in The New Competitive Pharma Market

  • Health Technology Assessment World Europe 2010

  • Innovation in Drug Discovery: Science & Technology

  • Innovation in Clinical Design: Analysis and Reporting

Home  |  Manufacturing  |  Products  |  Careers  |  Contact